BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 3, 2011
View Archived Issues
Additional data disclosed from ALLEGRO and BRAVO trials of laquinimod in RRMS
Read More
Initial treatment phase of rabeprazole trial in pediatric patients completed
Read More
Potential new target for MS therapy discovered at U.S. univeristy
Read More
Candidate vaccine for CDI-associated diarrhea is immunogenic and well tolerated
Read More
New therapeutic approach suggested for achalasia / News in Context
Read More
Pharmasset commences pivotal phase III program for interferon-free PSI-7977 regimen
Read More
Scientists at Amgen disclose new PI3K inhibitors
Read More
OncoTherapy Science patents novel PDZ-binding kinase inhibitors
Read More
Novel histone deacetylase inhibitors disclosed
Read More
AgonOx and MedImmune join to develop TNF receptor superfamily member 4 agonists
Read More
Array BioPharma and Genentech jointly synthesize new beta-secretase 1 inhibitors
Read More
Novel receptor-interacting protein 2 inhibitors prepared by GSK
Read More
Promising data disclosed from phase Ib trial of DB-959Na
Read More
Isis antisense drugs enter phase I development for type 2 diabetes
Read More
FDA sets PDUFA date for alogliptin and alogliptin/pioglitazone NDAs
Read More
Medivir reports final results from ASPIRE study
Read More
Furiex acquires exclusive license to develop MuDelta
Read More
FDA approves highly specific HPV assay
Read More
ExonHit extends strategic collaboration with Allergan
Read More
Resverlogix begins dosing in ASSURE study
Read More
FDA recommends approval of Vytorin in patients with predialysis chronic kidney disease
Read More
Meda files MAA for Dymista in Europe
Read More
Immunomedics resumes clivatuzumab tetraxetan study
Read More
Clonidine Lauriad receives European orphan drug status
Read More
Nuron Biotech starts phase III trial of NU-100 in MS
Read More
